<div id="readability-page-1"><p>Envestnet Asset Management Inc. boosted its stake in  Genpact Limited (NYSE:G - Free Report) by 64.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor  owned 533,566 shares of the business services provider's stock after purchasing an additional 208,762 shares during the period. Envestnet Asset Management Inc. owned approximately 0.31% of Genpact worth $22,351,000 at the end of the most recent reporting period.</p><ul><li>Generac Stock Rallies: Why AI Matters More Than Earnings</li></ul><p>Several other hedge funds also recently added to or reduced their stakes in the stock. Hussman Strategic Advisors Inc. purchased a new position in  Genpact in the 2nd quarter worth approximately $3,697,000.  Access Investment Management LLC purchased a new stake in shares of  Genpact during the second quarter valued at approximately $9,423,000.  Strs Ohio lifted its position in shares of  Genpact by 51.4% during the second quarter. Strs Ohio now owns 56,217 shares of the business services provider's stock worth $2,474,000 after purchasing an additional 19,075 shares in the last quarter.  Principal Financial Group Inc. boosted its stake in shares of  Genpact by 36.3% in the third quarter. Principal Financial Group Inc. now owns 497,105 shares of the business services provider's stock valued at $20,824,000 after purchasing an additional 132,310 shares during the period.  Finally, Allianz Asset Management GmbH grew its holdings in  Genpact by 153.6% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,597,446 shares of the business services provider's stock valued at $66,917,000 after purchasing an additional 967,559 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of equities analysts have commented on G shares. Mizuho cut their price objective on shares of Genpact from $51.00 to $49.00 and set a &#34;neutral&#34; rating on the stock in a report on Tuesday. Citigroup upgraded Genpact to a &#34;hold&#34; rating in a research note on Thursday, October 23rd. Susquehanna  set a $42.00 price target on Genpact in a report on Friday, February 6th. Wall Street Zen upgraded Genpact from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, January 10th. Finally, Needham &amp; Company LLC reduced their target price on Genpact from $53.00 to $50.00 and set a &#34;buy&#34; rating for the company in a research note on Friday, February 6th. One equities research analyst  has rated the stock with a Buy rating and seven have issued  a Hold rating to the company's stock. According to data from MarketBeat, the company  has a consensus rating of &#34;Hold&#34; and an average target price of $47.29.</p><ul><li>Amazon Bets Big on BETA: Why Analysts See 50% Upside</li></ul><p><b>Read Our Latest Research Report on Genpact</b></p><h2>Insider Activity</h2><p>In other Genpact news, SVP Sameer Dewan sold 15,088 shares of the business's stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total transaction of $703,855.20. Following the completion of the transaction, the senior vice president directly owned 37,749 shares in the company, valued at $1,760,990.85. The trade was a 28.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, SVP Riju Vashisht sold 16,016 shares of the firm's stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total transaction of $747,146.40. Following the completion of the sale, the senior vice president owned 95,521 shares in the company, valued at approximately $4,456,054.65. The trade was a 14.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own  3.07% of the company's stock. </p><h2>Genpact Stock Performance</h2><ul><li>IREN Bounces Back: The Market Votes Yes as Big Banks Step In</li></ul><p>NYSE G opened at $37.31 on Friday. The company's fifty day moving average is $45.18 and its two-hundred day moving average is $43.49. Genpact Limited has a 52-week low of $34.79 and a 52-week high of $55.55. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.66 and a quick ratio of 1.51. The firm has a market capitalization of $6.43 billion, a price-to-earnings ratio of 11.92, a P/E/G ratio of 1.07 and a beta of 0.74. </p><p>Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 5th. The business services provider reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.04. Genpact had a return on equity of 22.02% and a net margin of 10.88%.The business had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same period in the prior year, the company posted $0.91 earnings per share. Genpact's revenue was up 5.6% on a year-over-year basis. Genpact has set its FY 2026 guidance at 4.010-4.010 EPS and its Q1 2026 guidance at 0.920-0.930 EPS.  Equities research analysts forecast that  Genpact Limited will post 3.21 EPS for the current year. </p><h2>Genpact Increases Dividend</h2><p>The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Monday, March 16th will be issued a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a dividend yield of 2.0%. This is a boost from Genpact's previous quarterly dividend of $0.17. The ex-dividend date is Monday, March 16th. Genpact's dividend payout ratio  is 21.73%. </p><h2>Genpact Profile</h2> (Free Report)<p>Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.  </p><p>Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.  </p><p>Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Genpact</li><li>ALERT: Drop these 5 stocks before January 2026!</li><li>Trump &amp; Musk’s Secret Bet on Silver — Exposed</li><li>Silicon Valley insiders hint at 12-month AI warning</li><li>Buy This Stock Now</li><li>Is Trump Done? Shocking leak…</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUc?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUc"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Genpact Right Now?</h2><p>Before you consider Genpact, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.</p><p>While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

IDGT

XDAT

SRVR

CLOU

DTCR

<p>Envestnet Asset Management Inc. increased its stake in Genpact Limited by 64.3% in Q3, owning 533,566 shares valued at $22.35 million. Other hedge funds also adjusted their positions, with significant increases from Principal Financial Group and Allianz Asset Management. Analysts have mixed ratings on Genpact, with a consensus rating of "Hold" and an average target price of $47.29. Insider trading activity included sales by SVP Sameer Dewan and SVP Riju Vashisht. Genpact's stock performance shows a market cap of $6.43 billion and a current price of $37.31.</p>

Market Beat

Principal Financial

ISHRS S&P Glb It

iShares US Digital Infrastructure and Real Estate ETF

Franklin Exponential Data ETF

Pacer Data & Infrastructure Real Estate ETF

Proshares Big Data Refiners ETF

Global X Cloud Computing ETF

Genpact

SPDR S&P Software

Global X Data Center & Dgtl Infrs ETF

Genpact Limited $G Shares Acquired by Envestnet Asset Management Inc.